BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2019 10:38:02 AM | Browse: 1037 | Download: 1834
 |
Received |
|
2019-02-06 03:58 |
|
Peer-Review Started |
|
2019-02-12 06:08 |
|
First Decision by Editorial Office Director |
|
2019-06-04 17:56 |
|
Return for Revision |
|
2019-06-27 01:27 |
|
Revised |
|
2019-07-02 15:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-07-26 09:24 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-07-29 18:20 |
|
Articles in Press |
|
2019-07-29 18:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-09-06 06:19 |
|
Publish the Manuscript Online |
|
2019-09-12 10:38 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Advancements and challenges in treating advanced gastric cancer in the West
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jennifer L Leiting and Travis E Grotz |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Travis E Grotz, MD, Assistant Professor, Surgical Oncologist, Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, 200 First St. Southwest, Rochester, MN 55905, United States. grotz.travis@mayo.edu |
| Key Words |
Gastric cancer; D2 lymphadenectomy; Minimally invasive surgery; Neoadjuvant chemotherapy; Chemoradiation; Targeted treatments |
| Core Tip |
The treatment of advanced gastric cancer in the West continues to evolve and advance. Surgery-related outcomes continue to improve and have included the addition of minimally invasive surgery techniques. The use of chemotherapy to improve long-term survival outcomes has been demonstrated in randomized-controlled trials, though the best regimen to use continues to be investigated. Chemoradiation has also been shown to improve outcomes, though the timing, sequence, and patient-population for optimal benefit has yet to be determined. Targeted-therapies and intraperitoneal chemotherapy may also play a role in the treatment of patients with advanced gastric cancer. |
| Publish Date |
2019-09-12 10:38 |
| Citation |
Leiting JL, Grotz TE. Advancements and challenges in treating advanced gastric cancer in the West. World J Gastrointest Oncol 2019; 11(9): 652-664 |
| URL |
https://www.wjgnet.com/1948-5204/full/v11/i9/652.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v11.i9.652 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
